 NEW YORK, Oct. 7, 2021 PRNewswire -- DarioHealth Corp. Nasdaq: DRIO, a leader in the global digital therapeutics DTx market, announced today an agreement with a global company based in the United States Company to provide its integrated digital health management solution for diabetes, hypertension, and musculoskeletal MSK health. The contract is expected to launch in the first quarter of 2022. 